Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Tim Oliver"


2 mentions found


Gilead 's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday. The results bring Gilead one step closer to introducing a new form of pre-exposure prophylaxis, or PrEP, and broadening its HIV business. If those results are positive, the company could bring lenacapavir for PrEP to market as soon as late 2025. RBC Capital Markets analyst Brian Abrahams expects Gilead's shot will significantly increase the number of people interested in preventive HIV medicine. In its statement disclosing the lenacapavir trial results Thursday, Gilead said it plans to share an update on how it plans to address access in such countries where people suffer high incidence rates of HIV.
Persons: Gilead, Jared Baeten, Gilead's Truvada, Bruce Richman, Tim Oliver, they'd, Brian Abrahams, Gilead's, — CNBC's Leanne Miller Organizations: Food and Drug Administration, PrEP, Centers for Disease Control, Prevention, Health, FDA, RBC Capital Locations: U.S, New York
Bob Lee's peers and industry leaders wrote social media posts mourning the Cash App creator. At the company, the executive created Cash App, a mobile payment platform. YCombinator CEO Garry Tan called Lee's death a "huge loss for the tech community and for San Francisco." "We do not tolerate these horrific acts of violence in San Francisco," she tweeted. —Brooke Jenkins 謝安宜 (@BrookeJenkinsSF) April 5, 2023The San Francisco police department must conclude its investigation before the DA's office can step in, Randy Quezada, communications director at the San Francisco District Attorney's office, told Insider.
Total: 2